Bellevue Group AG
- SEC CIK
- 0001674546
- Latest filing
- Aug 14, 2026
Holdings in Q3 2021
Holdings as of Sep 30, 2021, filed Nov 12, 2021. Long positions only; changes compare share counts with Q2 2021.
- Positions
- 219
- +6 vs. Q2 2021
- Portfolio value
- $9.85B
- −$390.3M (−3.8%) vs. Q2 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MRNAModerna, Inc. | Stock | 1,727,349 | $664.8M | 6.7% | −814,951−32.1% | Reduced | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 1,761,616 | $319.5M | 3.2% | +27,922+1.6% | Added | History |
| IONSIonis Pharmaceuticals Inc | COM | 9,347,926 | $313.5M | 3.2% | −582,319−5.9% | Reduced | History |
| ARGXArgenx SE | SPONSORED ADR | 983,938 | $297.1M | 3.0% | +9,900+1.0% | Added | History |
| NBIXNeurocrine Biosciences Inc | Stock | 3,004,051 | $288.1M | 2.9% | −13,700−0.5% | Reduced | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 1,408,418 | $265.9M | 2.7% | −140,674−9.1% | Reduced | History |
| INCYIncyte Corp | COM | 2,957,000 | $203.4M | 2.1% | −14,400−0.5% | Reduced | History |
| ISRGIntuitive Surgical Inc | COM NEW | 203,595 | $202.4M | 2.1% | +1,500+0.7% | Added | History |
| AGIOAgios Pharmaceuticals, Inc. | COM | 4,341,992 | $200.4M | 2.0% | −11,000−0.3% | Reduced | History |
| FATEFate Therapeutics Inc | COM | 3,238,036 | $191.9M | 1.9% | +624,500+23.9% | Added | History |
| ARVNArvinas, Inc. | COM | 2,241,403 | $184.2M | 1.9% | +4,000+0.2% | Added | History |
| MGNXMacrogenics Inc | COM | 8,544,597 | $178.9M | 1.8% | +1,168,571+15.8% | Added | History |
| ELVElevance Health, Inc. | Stock | 475,210 | $177.2M | 1.8% | +9,234+2.0% | Added | History |
| ABTAbbott Laboratories | Stock | 1,387,499 | $163.9M | 1.7% | +10,000+0.7% | Added | History |
| BIIBBiogen Inc. | COM | 527,000 | $149.1M | 1.5% | −1,100−0.2% | Reduced | History |
| DXCMDexcom Inc | COM | 263,839 | $144.3M | 1.5% | +19,063+7.8% | Added | History |
| SAGESage Therapeutics, Inc. | COM | 3,209,004 | $142.2M | 1.4% | +844,800+35.7% | Added | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 3,773,919 | $140.7M | 1.4% | +164,000+4.5% | Added | History |
| DHRDanaher Corp | Stock | 456,679 | $139.0M | 1.4% | −26,261−5.4% | Reduced | History |
| UNHUnitedHealth Group Inc | Stock | 337,982 | $132.1M | 1.3% | −5,069−1.5% | Reduced | History |
| MYOVMyovant Sciences Ltd. | COM | 5,769,039 | $129.5M | 1.3% | +500,000+9.5% | Added | History |
| BSXBoston Scientific Corp | Stock | 2,967,127 | $128.7M | 1.3% | +640,340+27.5% | Added | History |
| TNDMTandem Diabetes Care Inc | COM NEW | 1,034,519 | $123.5M | 1.3% | +14,151+1.4% | Added | History |
| HUMHumana Inc | Stock | 312,762 | $121.7M | 1.2% | +30,007+10.6% | Added | History |
| RLAYRelay Therapeutics, Inc. | COM | 3,755,962 | $118.4M | 1.2% | +1,115,000+42.2% | Added | History |
| BDXBecton Dickinson & Co | Stock | 455,572 | $112.0M | 1.1% | −5,393−1.2% | Reduced | History |
| SYKStryker Corp | Stock | 422,332 | $111.4M | 1.1% | +77,818+22.6% | Added | History |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 974,684 | $109.1M | 1.1% | +7,800+0.8% | Added | History |
| PODDInsulet Corp | Stock | 382,994 | $108.9M | 1.1% | +60,875+18.9% | Added | History |
| AXNXAxonics, Inc. | COM | 1,608,794 | $104.7M | 1.1% | −121,677−7.0% | Reduced | History |
| ALGNAlign Technology Inc | COM | 157,031 | $104.5M | 1.1% | +261+0.2% | Added | History |
| JAZZJazz Pharmaceuticals plc | SHS USD | 769,238 | $100.2M | 1.0% | +224,488+41.2% | Added | History |
| EWEdwards Lifesciences Corp | Stock | 869,951 | $98.5M | 1.0% | −20,305−2.3% | Reduced | History |
| INSPInspire Medical Systems, Inc. | COM | 421,058 | $98.1M | 1.0% | +47,832+12.8% | Added | History |
| Radius Health, Inc.750469207 | COM NEW | 7,768,714 | $96.4M | 1.0% | +237,300+3.2% | Added | – |
| SWAVShockwave Medical, Inc. | COM | 464,247 | $95.6M | 1.0% | −52,668−10.2% | Reduced | History |
| RVMDRevolution Medicines, Inc. | COM | 3,458,805 | $95.2M | 1.0% | +1,604,000+86.5% | Added | History |
| EVHEvolent Health, Inc. | CL A | 3,032,678 | $94.0M | 1.0% | −605,733−16.6% | Reduced | History |
| INSMINSMED Inc | COM PAR $.01 | 3,385,645 | $93.2M | 0.9% | +264,744+8.5% | Added | History |
| HCAHCA Healthcare, Inc. | COM | 341,473 | $82.9M | 0.8% | +7,200+2.2% | Added | History |
| NKTRNektar Therapeutics | COM | 4,594,656 | $82.5M | 0.8% | +493,252+12.0% | Added | History |
| ACCDAccolade, Inc. | COM | 1,860,203 | $78.4M | 0.8% | +135,504+7.9% | Added | History |
| BMYBristol Myers Squibb Co | Stock | 1,302,934 | $77.1M | 0.8% | −160,498−11.0% | Reduced | History |
| SRRKScholar Rock Holding Corp | COM | 2,294,425 | $75.8M | 0.8% | −3,200−0.1% | Reduced | History |
| BAXBaxter International Inc | Stock | 923,223 | $74.3M | 0.8% | +22,600+2.5% | Added | History |
| IDXXIDEXX Laboratories Inc | COM | 118,120 | $73.5M | 0.7% | 00.0% | Unchanged | History |
| MTEMMolecular Templates, Inc. | COM | 10,878,003 | $73.0M | 0.7% | +1,249,382+13.0% | Added | History |
| CNCCentene Corp | Stock | 1,154,545 | $71.9M | 0.7% | −231,752−16.7% | Reduced | History |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 106,410 | $64.4M | 0.7% | +750+0.7% | Added | History |
| HOLXHologic Inc | COM | 870,662 | $64.3M | 0.7% | −43,090−4.7% | Reduced | History |
| HRCHill-Rom Holdings, Inc. | COM | 420,716 | $63.1M | 0.6% | −253,162−37.6% | Reduced | History |
| OPCHOption Care Health, Inc. | COM NEW | 2,595,814 | $63.0M | 0.6% | +805,622+45.0% | Added | History |
| GBIOGeneration Bio Co. | COM | 2,472,180 | $62.0M | 0.6% | −6,000−0.2% | Reduced | History |
| EXELExelixis, Inc. | COM | 2,859,000 | $60.4M | 0.6% | −73,000−2.5% | Reduced | History |
| OMCLOmnicell, Inc. | COM | 393,583 | $58.4M | 0.6% | 00.0% | Unchanged | History |
| GMEDGlobus Medical Inc | Stock | 729,420 | $55.9M | 0.6% | 00.0% | Unchanged | History |
| PENPenumbra Inc | COM | 205,692 | $54.8M | 0.6% | +23,567+12.9% | Added | History |
| ESPREsperion Therapeutics, Inc. | COM | 4,519,164 | $54.5M | 0.6% | 00.0% | Unchanged | History |
| BEAMBeam Therapeutics Inc. | COM | 612,821 | $53.3M | 0.5% | 00.0% | Unchanged | History |
| VCRAVocera Communications, Inc. | COM | 1,154,041 | $52.8M | 0.5% | +501,209+76.8% | Added | History |
| SRPTSarepta Therapeutics, Inc. | COM | 569,168 | $52.6M | 0.5% | +569,168 | New | History |
| VEEVVeeva Systems Inc | Stock | 174,551 | $50.3M | 0.5% | +1,904+1.1% | Added | History |
| TMOThermo Fisher Scientific Inc. | Stock | 86,879 | $49.6M | 0.5% | +44,905+107.0% | Added | History |
| ABMDAbiomed Inc | COM | 151,178 | $49.2M | 0.5% | 00.0% | Unchanged | History |
| IQVIQVIA Holdings Inc. | Stock | 190,620 | $45.7M | 0.5% | +13,220+7.5% | Added | History |
| MOHMolina Healthcare, Inc. | COM | 168,255 | $45.6M | 0.5% | −30,479−15.3% | Reduced | History |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 416,200 | $45.6M | 0.5% | −1,500−0.4% | Reduced | History |
| ADPTAdaptive Biotechnologies Corp | COM | 1,336,023 | $45.4M | 0.5% | +373,671+38.8% | Added | History |
| AMEDAmedisys Inc | COM | 302,798 | $45.1M | 0.5% | +242,311+400.6% | Added | History |
| CICigna Group | Stock | 217,812 | $43.6M | 0.4% | −38,930−15.2% | Reduced | History |
| SILKSilk Road Medical Inc | COM | 781,660 | $43.0M | 0.4% | −512,099−39.6% | Reduced | History |
| MDTMedtronic plc | Stock | 339,125 | $42.5M | 0.4% | −20,500−5.7% | Reduced | History |
| GHGuardant Health, Inc. | COM | 339,894 | $42.5M | 0.4% | −39,715−10.5% | Reduced | History |
| PACBPacific Biosciences of California, Inc. | COM | 1,643,159 | $42.0M | 0.4% | 00.0% | Unchanged | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 280,082 | $41.0M | 0.4% | 00.0% | Unchanged | History |
| EXASExact Sciences Corp | COM | 429,273 | $41.0M | 0.4% | +153,600+55.7% | Added | History |
| EPIXESSA Pharma Inc. | COM NEW | 5,034,814 | $40.3M | 0.4% | +2,575,000+104.7% | Added | History |
| MRSNMersana Therapeutics, Inc. | COM | 4,261,000 | $40.2M | 0.4% | +1,320,000+44.9% | Added | History |
| KZRKezar Life Sciences, Inc. | COM | 4,533,148 | $39.2M | 0.4% | 00.0% | Unchanged | History |
| PHRPhreesia, Inc. | COM | 622,542 | $38.4M | 0.4% | 00.0% | Unchanged | History |
| HALOHalozyme Therapeutics, Inc. | COM | 921,500 | $37.5M | 0.4% | −1,302,966−58.6% | Reduced | History |
| HCMHUTCHMED (China) Ltd | SPONSORED ADS | 1,006,147 | $36.8M | 0.4% | +141,387+16.3% | Added | History |
| TFXTeleflex Inc | COM | 97,818 | $36.8M | 0.4% | −2,343−2.3% | Reduced | History |
| HCATHealth Catalyst, Inc. | COM | 727,233 | $36.4M | 0.4% | −26,388−3.5% | Reduced | History |
| MASIMasimo Corp | COM | 127,713 | $34.6M | 0.4% | 00.0% | Unchanged | History |
| BIOBio-Rad Laboratories, Inc. | CL A | 46,015 | $34.3M | 0.3% | −41,286−47.3% | Reduced | History |
| TXG10x Genomics, Inc. | CL A COM | 232,672 | $33.9M | 0.3% | 00.0% | Unchanged | History |
| COOCooper Companies, Inc. | COM NEW | 74,266 | $30.7M | 0.3% | 00.0% | Unchanged | History |
| ABBVAbbVie Inc. | Stock | 282,900 | $30.5M | 0.3% | −41,300−12.7% | Reduced | History |
| QTRXQuanterix Corp | COM | 593,819 | $29.6M | 0.3% | −43,996−6.9% | Reduced | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 3,463,000 | $29.3M | 0.3% | 00.0% | Unchanged | History |
| ATRCAtriCure, Inc. | COM | 418,016 | $29.1M | 0.3% | +43,598+11.6% | Added | History |
| ILMNIllumina, Inc. | COM | 70,130 | $28.4M | 0.3% | −5,200−6.9% | Reduced | History |
| TDOCTeladoc Health, Inc. | COM | 215,906 | $27.4M | 0.3% | −42,042−16.3% | Reduced | History |
| NEONeogenomics Inc | COM NEW | 561,683 | $27.1M | 0.3% | −256,630−31.4% | Reduced | History |
| CRLCharles River Laboratories International, Inc. | COM | 63,329 | $26.1M | 0.3% | −114,941−64.5% | Reduced | History |
| NVRONevro Corp | COM | 214,956 | $25.0M | 0.3% | +31,755+17.3% | Added | History |
| AXSMAxsome Therapeutics, Inc. | COM | 752,945 | $24.8M | 0.3% | +400,924+113.9% | Added | History |
| RMDResmed Inc | COM | 88,145 | $23.2M | 0.2% | 00.0% | Unchanged | History |
| OMOutset Medical, Inc. | COM | 457,060 | $22.6M | 0.2% | 00.0% | Unchanged | History |
Options (1)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| Curevac N VN2451R105 | COM | – | $1.00K |
Sold out since Q2 2021 (7)
Positions held at the end of Q2 2021 that are gone from this filing.
| Security | Class | Shares in Q2 2021 | Value in Q2 2021 | % of portfolio in Q2 2021 | History |
|---|---|---|---|---|---|
| EAREargo, Inc. | COM | 434,054 | $17.3M | 0.2% | History |
| XENTIntersect ENT, Inc. | COM | 617,968 | $10.6M | 0.1% | History |
| SGFYSignify Health, Inc. | CL A COM | 200,000 | $6.09M | 0.1% | History |
| ALXNAlexion Pharmaceuticals, Inc. | COM | 14,300 | $2.63M | <0.1% | History |
| DRNADicerna Pharmaceuticals Inc | COM | 61,000 | $2.28M | <0.1% | History |
| ACADAcadia Pharmaceuticals Inc | COM | 65,900 | $1.61M | <0.1% | History |
| RXRXRecursion Pharmaceuticals, Inc. | CL A | 20,000 | $730.0K | <0.1% | History |